Precigen (PGEN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Precigen Revenue Highlights

Latest Revenue (Y)

$6.22M

Latest Revenue (Q)

$953.00K

Main Segment (Y)

Upfront And Milestone Payments

Main Geography (Y)

Non-US

Precigen Revenue by Period

Precigen Revenue by Year

Date	Revenue	Change
2023-12-31	$6.22M	-76.87%
2022-12-31	$26.91M	-74.09%
2021-12-31	$103.87M	0.67%
2020-12-31	$103.18M	13.73%
2019-12-31	$90.72M	-43.50%
2018-12-31	$160.57M	-30.48%
2017-12-31	$230.98M	20.98%
2016-12-31	$190.93M	9.98%
2015-12-31	$173.60M	141.35%
2014-12-31	$71.93M	202.74%
2013-12-31	$23.76M	70.63%
2012-12-31	$13.93M	73.78%
2011-12-31	$8.01M	-

Precigen generated $6.22M in revenue during NA 2023, up -76.87% compared to the previous quarter, and up 3.88% compared to the same period a year ago.

Precigen Revenue by Quarter

Date	Revenue	Change
2024-09-30	$953.00K	32.91%
2024-06-30	$717.00K	-32.68%
2024-03-31	$1.06M	-13.27%
2023-12-31	$1.23M	-92.66%
2023-09-30	$16.72M	846.35%
2023-06-30	$1.77M	-4.54%
2023-03-31	$1.85M	4.99%
2022-12-31	$1.76M	-89.46%
2022-09-30	$16.72M	474.44%
2022-06-30	$2.91M	-90.91%
2022-03-31	$32.02M	32.20%
2021-12-31	$24.22M	12.34%
2021-09-30	$21.56M	-35.79%
2021-06-30	$33.58M	37.00%
2021-03-31	$24.51M	26.78%
2020-12-31	$19.33M	-18.02%
2020-09-30	$23.58M	-22.49%
2020-06-30	$30.42M	1.96%
2020-03-31	$29.84M	75.50%
2019-12-31	$17.00M	-26.22%
2019-09-30	$23.04M	-35.97%
2019-06-30	$35.99M	54.21%
2019-03-31	$23.34M	-45.97%
2018-12-31	$43.19M	33.09%
2018-09-30	$32.45M	-28.33%
2018-06-30	$45.27M	3.27%
2018-03-31	$43.84M	-43.08%
2017-12-31	$77.03M	67.39%
2017-09-30	$46.02M	-15.46%
2017-06-30	$54.43M	1.28%
2017-03-31	$53.75M	16.84%
2016-12-31	$46.00M	-6.09%
2016-09-30	$48.98M	-6.70%
2016-06-30	$52.50M	20.86%
2016-03-31	$43.44M	4.67%
2015-12-31	$41.50M	-22.24%
2015-09-30	$53.37M	18.88%
2015-06-30	$44.89M	32.62%
2015-03-31	$33.85M	8.87%
2014-12-31	$31.09M	46.68%
2014-09-30	$21.20M	79.83%
2014-06-30	$11.79M	50.08%
2014-03-31	$7.85M	14.32%
2013-12-31	$6.87M	12.02%
2013-09-30	$6.13M	-9.56%
2013-06-30	$6.78M	70.55%
2013-03-31	$3.98M	-40.26%
2012-12-31	$6.66M	127.56%
2012-09-30	$2.92M	7.30%
2012-06-30	$2.73M	68.48%
2012-03-31	$1.62M	-

Precigen generated $953.00K in revenue during Q3 2024, up 32.91% compared to the previous quarter, and up 53.93% compared to the same period a year ago.

Precigen Revenue Breakdown

Precigen Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Upfront And Milestone Payments	$16.01M	$2.03M	$25.00M	$50.59M	$63.28M
Collaboration and licensing agreements	-	-	-	$2.17M	$16.30M
Other	-	-	-	-	$2.76M
Service	-	-	-	-	$52.42M
Product	-	-	-	-	$28.53M

Precigen's latest annual revenue breakdown by segment (product or service), as of Dec 22: Upfront And Milestone Payments (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Exemplar Segment	$953.00K	$717.00K	$1.38M	$1.77M	$1.85M	$1.65M	$2.10M	$2.84M	-	-	-	-	-	-	-	-	-	-	-	-
Biopharmaceuticals Segment	-	-	-	-	-	$116.00K	$14.62M	$70.00K	$367.00K	$1.27M	$503.00K	$419.00K	-	-	-	-	-	-	-	-
Reportable Segments	-	-	-	$1.77M	$1.85M	$1.76M	$16.72M	$2.91M	$33.61M	$24.49M	$22.83M	$33.76M	$24.86M	-	-	-	-	-	-	-
Trans Ova Segment	-	-	-	-	$1.85M	$20.64M	$18.35M	$29.86M	$21.18M	$15.41M	$15.28M	$23.93M	-	-	-	-	-	-	-	-
PGEN Therapeutics Segment	-	-	-	-	-	-	-	-	-	-	-	-	-	$-467.00K	$2.16M	$1.83M	-	-	-	-
Human Biotherapeutics Segment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Segments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$624.00K	-	-	-
Precigen ActoBio Segment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.00K	-	-	-	-
MBP Titan Segment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collaboration and licensing agreements	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$100.00K	$431.00K	$533.00K	-
Upfront And Milestone Payments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$40.21M	$74.39M	$78.17M	-
Product	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$5.85M	$7.82M
Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.08M	$670.00K
Service	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$9.92M	$18.40M

Precigen's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Exemplar Segment (100.00%).

Precigen Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Non-US	$233.00K	$530.00K	$595.00K	$1.40M	$11.95M

Precigen's latest annual revenue breakdown by geography, as of Dec 22: Non-US (100.00%).

Quarterly Revenue by Country

Country	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Non-US	$16.00K	$63.00K	$70.00K	$205.00K	$87.00K	$93.00K	$251.00K	$99.00K	$114.00K	$118.00K	$122.00K	$241.00K	$3.33M	$2.19M	$2.27M	$1.56M	$2.23M	$3.95M	$4.43M

Precigen's latest quarterly revenue breakdown by geography, as of Dec 22: Non-US (100.00%).

Precigen Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SGMO	Sangamo Therapeutics	$176.23M	$356.00K
AGEN	Agenus	$156.31M	$25.11M
ADAP	Adaptimmune Therapeutics	$60.28M	$128.23M
PTGX	Protagonist Therapeutics	$60.00M	$4.67M
AFMD	Affimed	$8.28M	$155.00K
PGEN	Precigen	$6.22M	$953.00K
IMMP	Immutep	$3.51M	$2.11M
MRKR	Marker Therapeutics	$3.31M	$1.93M
CRVS	Corvus Pharmaceuticals	-	-
APTO	Aptose Biosciences	-	-
DAWN	Day One Biopharmaceuticals	-	$20.07M
SELB	Cartesian Therapeutics	-	$6.55M
INZY	Inozyme Pharma	-	-
LPTX	Leap Therapeutics	-	-
CRMD	CorMedix	-	$11.46B
SNDX	Syndax Pharmaceuticals	-	$12.50M
ZNTL	Zentalis Pharmaceuticals	-	-
EWTX	Edgewise Therapeutics	-	-

PGEN Revenue FAQ

What is Precigen’s yearly revenue?

Precigen's yearly revenue for 2023 was $6.22M, representing a decrease of -76.87% compared to 2022. The company's yearly revenue for 2022 was $26.91M, representing a decrease of -74.09% compared to 2021. PGEN's yearly revenue for 2021 was $103.87M, representing an increase of 0.67% compared to 2020.

What is Precigen’s quarterly revenue?

Precigen's quarterly revenue for Q3 2024 was $953K, a 32.91% increase from the previous quarter (Q2 2024), and a -94.30% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $717K, a -32.68% decrease from the previous quarter (Q1 2024), and a -59.42% decrease year-over-year (Q2 2023). PGEN's quarterly revenue for Q1 2024 was $1.06M, a -13.27% decrease from the previous quarter (Q4 2023), and a -42.46% decrease year-over-year (Q1 2023).

What is Precigen’s revenue growth rate?

Precigen's revenue growth rate for the last 3 years (2021-2023) was -94.01%, and for the last 5 years (2019-2023) was -93.14%.

What are Precigen’s revenue streams?

Precigen's revenue streams in c 22 are Upfront And Milestone Payments

What is Precigen’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Precigen was Upfront And Milestone Payments. This segment made a revenue of $16.01M, representing 100.00% of the company's total revenue.